Woodmont Investment Counsel’s Cumberland Pharmaceuticals CPIX Stock Holding History

Woodmont Investment Counsel’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	-$10K	–	275
2016 Q3	$10K	Buy	+2,000	New	+$9.41K	﹤0.01%	467
2016 Q2	–	Sell	-2,000	Closed	-$9K	–	239
2016 Q1	$9K	Hold	2,000	–	–	﹤0.01%	421
2015 Q4	$11K	Hold	2,000	–	–	﹤0.01%	413
2015 Q3	$12K	Hold	2,000	–	–	﹤0.01%	414
2015 Q2	$14K	Buy	+2,000	New	+$13.9K	﹤0.01%	392
2013 Q3	–	Sell	-10,000	Closed	-$51K	–	159
2013 Q2	$51K	Buy	+10,000	New	+$49.8K	0.02%	192

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Woodmont Investment Counsel's CPIX Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2016, closing a stake of 2,000 shares — an estimated $10K sold.

Woodmont Investment Counsel first reported a position in CPIX in Q2 2013 and held it in 6 quarters. The position peaked at $51K in Q2 2013. 41 funds tracked by Wall St. Rank hold CPIX as of Q4 2016.

Woodmont Investment Counsel reported no remaining Cumberland Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Woodmont Investment Counsel sold 2,000 Cumberland Pharmaceuticals shares in Q4 2016, an estimated $10K.
Woodmont Investment Counsel first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Woodmont Investment Counsel's Cumberland Pharmaceuticals position peaked at $51K in Q2 2013.
41 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.